NXL - Rasio kapitalisasi pasar marang pendapatan Nexalin Technology, Inc.

Nexalin Technology, Inc. (NXL) holds patents for neurostimulation frequencies used to combat depression, ensuring long-term revenue. The price-to-sales multiple on the GURU.Markets system consolidated chart shows that the indicator level is 7.80. Business growth is based on FDA approvals, although vulnerability in protection necessitates expanded insurance coverage and recognition of the method by leading clinics.

For Nexalin Technology, Inc. (NXL), which develops non-invasive brain stimulation systems, the P/S ratio serves as a measure of market value relative to revenue. This metric is calculated by dividing the total market capitalization by annual sales volume. By analyzing the price-to-sales trend, an investor determines the extent of the premium paid for the innovative potential of the neurobiological product. The stability of this indicator confirms the adequacy of the business valuation amid the scaling of medical technologies.